Trade STAAR Surgical Co - STAA CFD

STAAR Surgical Company Company profile

About STAAR Surgical Company

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. It operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, STAAR Surgical Company revenues increased 41% to $230.5M. Net income increased from $5.9M to $24.5M. Revenues reflect ICLs segment increase of 51% to $212.9M, China segment increase of 50% to $107.3M, Others segment increase of 42% to $72.1M. Net income benefited from Royalty income increase from $440K to $1M (income), Int exp on Financial Lease liab. decrease of 80% to $6K (expense).

Equity composition

Common Stock $.01 Par, 3/11, 60M auth., 35,270,846 issd., Insiders own 2.03%. PO: 7/83, 640K shs @$6.25 by D.H. Blair.5/90 - 9/90, 2.9M shares issd.;2/91, 1,626,490 units (1 shs com. & 1 war.) @ $.90/unit.Preferred Stock $.01 Par, 10M auth., Ser.A redeemable convertible 0 issd.